PMCB vs QGEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

PMCB

38.5
AI Score
VS
QGEN Wins

QGEN

48.5
AI Score

Investment Advisor Scores

PMCB

39score
Recommendation
SELL

QGEN

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PMCB QGEN Winner
Net Income -19.42M 424.88M QGEN
Operating Income -6.85M 465.85M QGEN
ROE -58.3% 11.2% QGEN
ROA -41.5% 6.8% QGEN
Total Assets 46.75M 6.28B QGEN
Cash 18.60M 839.00M QGEN
Current Ratio 45.28 3.90 PMCB

Relative Price Performance (Last 90 Days)

PMCB 1M: -17.8% · 3M: -40.0% QGEN 1M: -1.2% · 3M: +13.6%

Current Technical Phase

PMCB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.3%), weak momentum, RSI 27

RSI (14): 27.4 · Price: $0.45

QGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.2 · Price: $42.50

Fundamentals Snapshot

Metric PMCB QGEN
Market Cap
Forward P/E 7.0 16.3
Trailing P/E 21.6
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.7%
Operating Margin 0.0% 0.3%
EPS -2.77 1.95
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, QGEN is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.